bob hugen is an amazing manager.mendously that people had such little faith in celgene after all they had done for shareholders. does that take care of this risk of -- >> the challenge of -- >> yes. >> kyle bass will say nothing will take care of the risk. he will say he can challenge all these patents. bob hugen said that won't be an issue either. certain ceos, when they say it, they're not just making it out of whole cloth. he had tremendous conviction on this patent. the street did not, which is why you're seeing such a radical rerating of celgene. this is what happens when you have no patent cliff. stock to 130. 130 is where we fairly value the rest of the group. >> nike by far the best dow component today. takes the yearly gain to 41%, jim. no dow component has done better this year. >> nike coming in. the worries about china, china is their best. the worries about people spending more on sneakers in an era when people are frugal. yes, they will spend more. an environment where technology is not considered key t